Stem Save Invest in your child's future
 
Select Country

Share

 
   
Sign In Create an account
Forgot password?
Search Easy Ship
877-783-6728 (877-StemSave)

 

Stem Cell Research Center
 Published Medical Research
 Video Center
 Scientific Advisory Council


Published Research
  Select a Topic
Dental Stem Cells
Adult Stem Cells
Regenerative Therapies
Dental Regenerative Therapies
Other Stem Cell News
Dental Follicle Stem Cells
Salivary Gland Regeneration
Mandibular Reconstruction
Maxillary and Cleft Palate Reconstruction
Dental Stem Cell Cryopreservation
Gingival Stem Cells
Dental Implants
Dental iPS cells
Periodontal Stem cells
  View All
 

 

 

 

 

 

 

 

Stem Cell Research Center

Published Medical Research

Dental Stem Cells
01/04/2012 - Differentiation of dental pulp stem cells into islet-like aggregates.
The post-natal dental pulp tissue contains a population of multipotent mesenchymal progenitor cells known as dental pulp stromal/stem cells (DPSCs), with high proliferative potential for self-renewal. In this investigation, we explored the potential of DPSCs to differentiate into pancreatic cell lineage resembling islet-like cell aggregates (ICAs). We isolated, propagated, and characterized DPSCs and demonstrated that these could be differentiated into adipogenic, chondrogenic, and osteogenic lineage upon exposure to an appropriate cocktail of differentiating agents. Using a three-step protocol reported previously by our group, we succeeded in obtaining ICAs from DPSCs. The identity of ICAs was confirmed as islets by dithiozone-positive staining, as well as by expression of C-peptide, Pdx-1, Pax4, Pax6, Ngn3, and Isl-1. There were several-fold up-regulations of these transcription factors proportional to days of differentiation as compared with undifferentiated DPSCs. Day 10 ICAs released insulin and C-peptide in a glucose-dependent manner, exhibiting in vitro functionality. Our results demonstrated for the first time that DPSCs could be differentiated into pancreatic cell lineage and offer an unconventional and non-controversial source of human tissue that could be used for autologous stem cell therapy in diabetes.

Source - Stempeutics Research Malaysia Sdn Bhd, (773817-K), Lot G-E-2A, Enterprise 4, Technology Park Malaysia, Bukit Jalil, 57000 Kuala Lumpur, Malaysia.
Download
 
12/06/2011 - Dental Stem Cells Promote Spinal Cord Regeneration After Injury
Recently, a team of researchers at the Nagoya University Graduate School of Medicine, motivated by the knowledge that stem cells taken from tooth pulp are capable of stimulating long-term regeneration of nerves in damaged spinal cords, tested the ability of dental stem cells to treat said injuries. The results have positively demonstrated that dental stem cells not only “promoted the   regeneration of transected axons by directly inhibiting multiple axon growth inhibitors,” but also, “prevented a damage-induced apoptosis,” and were able to replaced the original cells that were lost due to injury.

“To our knowledge, the latter two neuroregenerative activities are unique to tooth-derived stem cells and are not exhibited by any other previously described stem cells,” the researchers stated. “We propose that tooth-derived stem cells may be an excellent and practical cellular resource for the treatment of SCI [spinal cord injury].”

The era of regenerative medicine is now.

To read the full article click here.
Download
 
11/13/2011 - Stem cells in dental pulp of deciduous teeth
Dental pulp from deciduous (baby) teeth, which are discarded after exfoliation, represents an advantageous source of young stem cells. Herein, we discuss the methods of Deciduous Teeth Stem Cells (DTSCs) isolation and cultivation. We show that based on these methods, at least three different stem cells populations can be identified: a population similar to bone marrow derived mesenchymal stem cells (BM-MSCs), an epithelial stem-like cells (ESCs) and/or a mixed population composed of both cell types. We analyzed the embryonic origin and stem cell niche of DTSCs with respect to the advantages they can provide for their future use in cell therapies and regenerative medicine. In vitro and in vivo differentiation of the DTSCs populations, their developmental potential, immunological compatibility, tissues engineering, transplantation use in studies in animal models are also the focus of the present report. We briefly describe the derivation of induced pluripotent stem (iPS) cells from DTSCs, which can be obtained more easily and efficiently in comparison with human fibroblasts. These iPS cells represent an interesting model for the investigation of pediatric diseases and disorders. The importance of DTSCs banking is also discussed.

Butantan, Genetics, av. Vital Brasil, 1500, São Paulo, Brazil, 05503-900, 55 11 3726 7222; ikerkis@butantan.gov.br.

Download
 
10/28/2011 - Human dental pulp cells: a new source of cell therapy in a mouse model of compressive spinal cord injury.
J Neurotrauma. 2011 Sep;28(9):1939-49. Epub 2011 Aug 8.

Programa de Pesquisa em Neurociência Básica e Clínica, Instituto de Ciências Biomédicas, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Brazil.

Strategies aimed at improving spinal cord regeneration after trauma are still challenging neurologists and neuroscientists throughout the world. Many cell-based therapies have been tested, with limited success in terms of functional outcome. In this study, we investigated the effects of human dental pulp cells (HDPCs) in a mouse model of compressive spinal cord injury (SCI). These cells present some advantages, such as the ease of the extraction process, and expression of trophic factors and embryonic markers from both ecto-mesenchymal and mesenchymal components. Young adult female C57/BL6 mice were subjected to laminectomy at T9 and compression of the spinal cord with a vascular clip for 1?min. The cells were transplanted 7 days or 28 days after the lesion, in order to compare the recovery when treatment is applied in a subacute or chronic phase. We performed quantitative analyses of white-matter preservation, trophic-factor expression and quantification, and ultrastructural and functional analysis. Our results for the HDPC-transplanted animals showed better white-matter preservation than the DMEM groups, higher levels of trophic-factor expression in the tissue, better tissue organization, and the presence of many axons being myelinated by either Schwann cells or oligodendrocytes, in addition to the presence of some healthy-appearing intact neurons with synapse contacts on their cell bodies. We also demonstrated that HDPCs were able to express some glial markers such as GFAP and S-100. The functional analysis also showed locomotor improvement in these animals. Based on these findings, we propose that HDPCs may be feasible candidates for therapeutic intervention after SCI and central nervous system disorders in humans.

Download
 
10/28/2011 - Feeder-free derivation of induced pluripotent stem cells from human immature dental pulp stem cells.
Cell Transplant. 2011 Apr 1.


Induced pluripotent stem cells (iPSC) can be created by forcing expression of certain genes in fibroblasts or other somatic cell types, reversing them to a pluripotent state similar to that of embryonic stem cells (ESC). Here, we used human immature dental pulp stem cells (hIDPSC) as an alternative source for creating iPSC. HIDPSC can be easily isolated from accessible tissue of young and adult patients. HIDPSC possess a fibroblast-like morphology, retaining characteristics of adult multipotent stem cells. Reprogramming of hIDPSC was fast, producing primary hIDPSC-iPSC colonies even under feeder-free conditions. hIDPSC acquired ESC-like morphology, expressed pluripotent markers, possessed stable, normal karyotypes and demonstrate the ability to differentiated in vitro and in vivo. Our data demonstrate that hIDPSC-iPSC offer an advantageous cell system for future cell therapy and basic studies, particularly as a model for pediatric developmental disorders.

Download
 
09/03/2011 - Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells.

Department of Stem Cell, Center for Stem Cell and Gene Therapies Research and Practice, Institute of Health Sciences, Kocaeli University, 41380, Kocaeli, Turkey, ekaraoz@hotmail.com.

Dental pulp stem cells (hDP-SCs) were primarily derived from pulp tissues of primary incisors, exfoliated deciduous and permanent third molar teeth. To understand the characteristics of hDP-SCs from impacted third molar, proliferation capacities, gene expression profiles, phenotypic, ultrastructural, and differentiation characteristics were analyzed in comparison with human bone marrow-derived mesenchymal stem cells (hBM-MSCs), extensively. hDP-SCs showed more developed and metabolically active cells. Contrary to hBM-MSCs, hDP-SCs strongly expressed both cytokeratin (CK)-18 and -19, which could involve in odontoblast differentiation and dentine repair. The intrinsic neuro-glia characteristics of hDP-MSCs were demonstrated by the expression of several specific transcripts and proteins of neural stem cell and neurons. These cells not only differentiate into adipogenic, osteogenic, and chondrogenic lineage, but also share some special characteristics of expressing some neural stem cell and epithelial markers. Under defined conditions, hDP-SCs are able to differentiate into both neural and vascular endothelial cells in vitro. Dental pulp might provide an alternative source for human MSCs. hDP-SCs with a promising differentiation capacity could be easily isolated, and possible clinical use could be developed for neurodegenerative and oral diseases in the future.

Download
 
07/30/2011 - Differentiation and Neuro-Protective Properties of Immortalized Human Tooth Germ Stem Cells.
Neurochem Res. 2011 Jul 22.

Department of Genetics and BioEngineering, College of Engineering and Architecture, Yeditepe University, 26 Agustos Campus, Kayisdagi cad, Kayisdagi, 34755, Istanbul, Turkey.

Stem cells are considered to be promising therapeutic options in many neuro-degenerative diseases and injuries to the central nervous system, including brain ischemia and spinal cord trauma. Apart from the gold standard embryonic and mesenchymal origin, human tooth germ stem cells (hTGSCs) have also been shown to enjoy the characteristics of mesenchymal stem cells (MSCs) and the ability to differentiate into adipo-, chondro-, osteo- and neuro-genic cells, suggesting that they might serve as potential alternatives in the cellular therapy of various maladies. Immortalization of stem cells may be useful to avoid senescence of stem cells and to increase their proliferation potential without altering their natural characteristics. This study evaluated the expression of stem cell markers, surface antigens, differentiation capacity, and karyotype of hTGSCs that have been immortalized by human telomerase reverse transcriptase (hTERT) or simian vacuolating virus 40 (SV40) large T antigen. These undying cells were also evaluated for their neuro-protective potential using an in vitro SH-SY5Y neuro-blastoma model treated with hydrogen-peroxide or doxo-rubicin. Although hTGSC-SV40 showed abnormal karyotypes, our results suggest that hTGSC-hTERT preserve their MSC characteristics, differentiation capacity and normal karyotype, and they also possess high proliferation rate and neuro-protective effects even at great passage numbers. These peculiars indicate that hTGSC-hTERT could be used as a viable model for studying adipo-, osteo-, odonto- and neuro-genesis, as well as neuro-protection of MSCs, which may serve as a springboard for potentially utilizing dental waste material in cellular therapy.

Download
 
07/30/2011 - Isolation of pluripotent stem cells from human third molar dental pulp.
Histol Histopathol. 2011 Aug;26(8):1057-70.

Regenerative Medicine Laboratory, Universitat Internacional de Catalunya, Barcelona, Spain.

Potent stem/progenitor cells have been isolated from normal human dental pulps, termed dental pulp stem cells (DPSCs). However, no study has described the presence of stem cell populations in human dental pulp from the third molar with embryonic phenotypes. The dental pulp tissue was cultured in media with the presence of LIF, EGF, and PDGF. In the present study, we describe a new population of pluripotent stem cells that were isolated from dental pulp (DPPSC). These cells are SSEA-4+, Oct4+, Nanog+, FLK-1+, HNF3beta+, Nestin+, Sox2+, Lin28+, c-Myc+, CD13+, CD105+, CD34-, CD45-, CD90low, CD29+, CD73low, STRO-1low and CD146-. We have investigated by SEM analysis and q-RT-PCR the capacity of DPPSCs to 3D differentiate in vitro using the Cell Carrier 3D glass scaffold into tissues that have similar characteristics to embryonic mesoderm and endoderm layers. These data would support the use of these cells, which are derived from an easily accessible source and can be used in future regeneration protocols for many tissue types that differentiate from the three embryonic layers.

Download
 
07/30/2011 - Induced in vitro differentiation of neural-like cells from human exfoliated deciduous teeth-derived stem cells.
Int J Dev Biol. 2011;55(2):189-95.

Pediatric Department, School of Dentistry, 2Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Stem cells from human exfoliated deciduous teeth (SHED) are highly proliferative, clonogenic and multipotent stem cells with a neural crest cell origin. Additionally, they can be collected with minimal invasiveness in comparison with other sources of mesenchymal stem cells (MSCs). Therefore, SHED could be a desirable option for potential therapeutic applications. In this study, SHEDs were established from enzyme-disaggregated deciduous dental pulp obtained from 6 to 9 year-old children. The cells had typical fibroblastoid morphology and expressed antigens characteristic of MSCs, STRO1, CD146, CD45, CD90, CD106 and CD166, but not the hematopoietic and endothelial markers, CD34 and CD31, as assessed by FACS analysis. Differentiation assessment revealed a strong osteogenic and adipogenic potential of SHEDs. In order to further evaluate the in vitro differentiation potential of SHED into neural cells, a simple short time growth factor-mediated induction was used. Immunofluorescence staining and flow cytometric analysis revealed that SHED rapidly expressed nestin and b-III tubulin, and later expressed intermediate neural markers. In addition, the intensity and percentages of nestin and b-III tubulin and mature neural markers (PSA-NCAM, NeuN, Tau, TH, or GFAP) increased significantly following treatment. Moreover, RT-PCR and Western blot analyses showed that the neural markers were strongly up-regulated after induction. In conclusion, these results provide evidence that SHED can differentiate into neural cells by the expression of a comprehensive set of genes and proteins that define neural-like cells in vitro. SHED cells might be considered as new candidates for the autologous transplantation of a wide variety of neurological diseases and neurotraumatic injuries.

Download
 
07/30/2011 - Pulp tissue from primary teeth: new source of stem cells.
J Appl Oral Sci. 2011 May-Jun;19(3):189-94.

Department of Community Dentistry and Pediatric Dentistry, Dental School, Federal University of Bahia, Salvador, BA, Brazil. p-telles@uol.com.br

SHED (stem cells from human exfoliated deciduous teeth) represent a population of postnatal stem cells capable of extensive proliferation and multipotential differentiation. Primary teeth may be an ideal source of postnatal stem cells to regenerate tooth structures and bone, and possibly to treat neural tissue injury or degenerative diseases. SHED are highly proliferative cells derived from an accessible tissue source, and therefore hold potential for providing enough cells for clinical applications. In this review, we describe the current knowledge about dental pulp stem cells and discuss tissue engineering approaches that use SHED to replace irreversibly inflamed or necrotic pulps with a healthy and functionally competent tissue that is capable of forming new dentin.

Download
 
05/01/2011 - Dual origin of mesenchymal stem cells contributing to organ growth and repair.
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6503-8. Epub 2011 Apr 4.

Department of Craniofacial Development and Comprehensive Biomedical Research Centre, Dental Institute, Kings College London, London SE1 9RT, United Kingdom.

In many adult tissues, mesenchymal stem cells (MSCs) are closely associated with perivascular niches and coexpress many markers in common with pericytes. The ability of pericytes to act as MSCs, however, remains controversial. By using genetic lineage tracing, we show that some pericytes differentiate into specialized tooth mesenchyme-derived cells-odontoblasts-during tooth growth and in response to damage in vivo. As the pericyte-derived mesenchymal cell contribution to odontoblast differentiation does not account for all cell differentiation, we identify an additional source of cells with MSC-like properties that are stimulated to migrate toward areas of tissue damage and differentiate into odontoblasts. Thus, although pericytes are capable of acting as a source of MSCs and differentiating into cells of mesenchymal origin, they do so alongside other MSCs of a nonpericyte origin. This study identifies a dual origin of MSCs in a single tissue and suggests that the pericyte contribution to MSC-derived mesenchymal cells in any given tissue is variable and possibly dependent on the extent of the vascularity.

Download
 
03/08/2011 - 03/08/2011 - Type 1 diabetes stem cell treatment advances utilizing autologous dental stem cells
by Doctor Dharmini Pathmanathan, DMD, PhD

Diabetes is a chronic degenerative disease of the beta-cells of the pancreas leading to a lifelong dependency on insulin treatments.  While the cure for diabetes would be transplantation of cadaveric pancreatic islet cells to the diabetic individual, the scarcity of transplantable organs and side effects arising from a lifelong immunosuppressive regimen limits its therapeutic potential and is thus far from an ideal option. Similarly, the use of embryonic stem cells (ES), a favored option due to enormous differentiation potential of ES, is limited in its application in regenerative medicine because of persistent ethical and legal concerns. Thus, mesenchymal stem cells (MSCs) have been extensively studied for their ability to differentiate into insulin-producing cells. However, limited sources and the invasive procedures necessary to procure these cells restrict their application.  Given the limitations of the above procedures, locating a source of MSCs that is readily available and accessible and without any significant donor morbidity would be an ideal solution. Recent article in the Journal of Dental Research presented a benchmark study in which dental pulp stem cells (DPSCs) were differentiated into functional pancreatic cells. DPSCs were isolated from deciduous teeth that were already planned for serial extraction as part of orthodontic management. In short, the DPSCs were differentiated to islet-like cell aggregates (ICAs) using various growth factors and their identity confirmed using expression studies. In vitro functional studies showing that the DPSCs differentiated into ICAs could indeed respond to a glucose challenge with insulin production provided further confirmation for their potential use in islet transplantation programs. These findings add to the body of evidence regarding DPSCs ability to be differentiated into pancreatic cell lineage and their potential as a source of human tissue that could be used for an autologous stem cell therapy for diabetes without fear of rejection. Since DPSCs do not have the same restrictions as ES, are readily accessible, can be harvested from the individual himself, and virtually eliminate the possibility of rejection and therefore the use of immunosuppressants, DPSCs are considered to be an ideal source for MSCs for emerging diabetes stem cell treatments. Beyond diabetes, these findings also validate and encourage the banking of dental pulp stem cells for use in autologous stem cell therapy.  

Download
 
03/07/2011 - Vascular endothelial growth factor enhances in vitro proliferation and osteogenic differentiation of human dental pulp stem cells.

J Biol Regul Homeost Agents. 2011 Jan-Mar;25(1):57-69.

D' Alimonte I, Nargi E, Mastrangelo F, Falco G, Lanuti P, Marchisio M, Miscia S, Robuffo I, Capogreco M, Buccella S, Caputi S, Caciagli F, Tetè S, Ciccarelli R.

Departments of Biomedical Sciences, University of Chieti, Italy

Mesenchymal stem cells (MSC), isolated from dental tissues, are largely studied for future application in regenerative dentistry. In this study, we used MSC obtained from human dental pulp (DPSC) of normal impacted third molars that, when cultured in lineage-specific inducing media, differentiate into osteoblasts and adipocytes (evaluated by Alizarin Red S and Red Oil O stainings, respectively), thus showing a multipotency. We confirmed that DPSC, grown under undifferentiating conditions, are negative for hematopoietic (CD45, CD31, CD34, CD144) and positive for mesenchymal (CD29, CD90, CD105, CD166, CD146, STRO-1) markers, that underwent down-regulation when cells were grown in osteogenic medium for 3 weeks. In this condition, they also exhibit an increase in the expression of osteogenic markers (RUNX-2, alkaline phosphatase) and extracellular calcium deposition, whereas the expression of receptors (VEGFR-1 and -2) for vascular endothelial growth factors (VEGF) and related VEGF binding proteins was similar to that found in undifferentiated DPSC. Exposure of DPSC growing under undifferentiating or osteogenic conditions to VEGF-A165 peptide (10-40 ng/ml) for 8 days dose- and time-dependently increased the number of proliferating cells without inducing differentiation towards endothelial lineage, as evaluated by the lack of expression of specific markers (CD31, CD34, CD144). Additionally, exposure of DPSC cultured in osteogenic medium to VEGF-A165 for a similar period enhanced cell differentiation towards osteoblasts as evaluated after 14 and 21 days by Alizarin Red S staining and alkaline phosphatase activity quantification. These findings may have clinical implications possibly facilitating tissue repair and remodeling.

Download
 
03/07/2011 - Comparative Analysis of Telomere Length, Telomerase and Reverse Transcriptase Activity in Human Dental Stem Cells.

Cell Transplant. 2011 Mar 8.

Byeong GJ, Kang EJ, Kumar BM, Maeng GH, Ock SA, Kwack DO, Park BW, Rho GJ.

Stem cells from dental tissues have been isolated and established for tooth regenerative applications. However, basic characterization on their biological properties still needs to be investigated before employing them for effective clinical trials. In this study, we compared the telomere length, relative telomerase activity ( RTA) and relative reverse transcriptase activity ( RRA) as well as the surface antigen profile and mesenchymal differentiation ability in human dental papilla stem cells ( DPaSCs) , dental pulp stem cells ( DPuSCs) and dental follicle stem cells ( DFSCs) with mesenchymal stem cells ( MSCs) derived from bone marrow. Dental stem cells ( DSCs) were strongly positive for cell surface markers, such as CD44 and CD90. However, slightly lower expression of CD105 was observed in DPaSCs and DPuSCs compared to DFSCs and MSCs. Following specific induction, DPaSCs, DFSCs and MSCs were successfully differentiated into adipocytes and osteocytes. However, DPuSCS, in particular, were able to differentiate into adipocytes but failed to induce into osteogenic differentiation. Further, all DSCs, MSCs, and MRC- 5 fibroblasts as control were investigated for telomere length by non- radioactive chemiluminescent assay, RTA by relative- quantitative telomerase repeat amplification protocol ( RQ- TRAP) , and RRA by PCR- based assay. Mean telomere lengths in DPaSCs, DPuSCs, DFSCs and MSCs was '11 kb, and the values did not differ significantly (P<0.05) among the cells analyzed. RTA levels in DPaSCs were significantly ( P<0. 05) higher than in MSCs, DPuSCs, DFSCs, and MRC- 5 fibroblasts and among DSCs, DFSCs showed a significantly ( P<0. 05) lower RTA. Moreover, RRA levels were significantly ( P<0. 05) higher in DPaSCs, DPuSCs and MSCs than in DFSCs. Based on these observations, we conclude that among DSCs, DPaSCs possessed ideal characteristics on telomere length, telomerase activity and reverse transcriptase ( RTase) activity, and may serve as suitable alternative candidates for regenerative medicine.

Download
 
03/01/2011 - Biomaterials coated by dental pulp cells as substrate for neural stem cell differentiation.
Abstract
This study is focused on the development of an in vitro hybrid system, consisting in a polymeric biomaterial covered by a dental pulp cellular stroma that acts as a scaffold offering a neurotrophic support for the subsequent survival and differentiation of neural stem cells. In the first place, the behavior of dental pulp stroma on the polymeric biomaterial based on ethyl acrylate and hydroxy ethyl acrylate copolymer was studied. For this purpose, cells from normal human third molars were grown onto 0.5-mm-diameter biomaterial discs. After cell culture, quantification of neurotrophic factors generated by the stromal cells was performed by means of an ELISA assay. In the second place, survival and differentiation of adult murine neural stem cells on the polymeric biomaterials covered by dental pulp stromal cells was studied. The results show the capacity of dental pulp cells to uniformly coat the majority of the material's surface and to secrete neurotrophic factors that become crucial for a subsequent differentiation of neural stem cells. The use of stromal cells cultured on scaffolding biomaterials provides neurotrophic pumps that may suggest new criteria for the design of cell therapy experiments in animal models to assist the repair of lesions in Central Nervous System. © 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2011J Biomed Mater Res A. 2011 Feb 11. doi: 10.1002/jbm.a.33032. [Epub ahead of print]

Soria JM, Sancho-Tello M, Esparza MA, Mirabet V, Bagan JV, Monleón M, Carda C.

Facultad Ciencias de la Salud, Universidad CEU Cardenal Herrera, Avda Seminario sn. 46113 Moncada, Valencia, Spain. jose.soria@uch.ceu.es.

Download
 
01/25/2011 - Dental Stem Cells to regrow and repair Salivary Glands.
By Doctor Dharmini Pathmanathan, DMD, PhD
 
Doctor Xing Yan, has been awarded a grant from the National Natural Science Foundation of China in the field of salivary gland regeneration utilizing dental stem cells.  Dr. Yan will collaborate with Dr. George Huang, a StemSave Scientific Advisor on this important research project.  The purpose of the research is to study the functional regeneration of salivary glands, specifically the parotid glands damaged by radiation, using induced pluripotent stem (iPS) cells reprogrammed from dental pulp stem cells. Salivary gland stem cells and iPS cells differentiated into salivary gland cells will be isolated and using animal models will be tested for their ability to regenerate a functional salivary gland. 
 
While primary salivary gland tumors are rare, surgical and radiation treatments can have adverse consequences to salivary gland function. Annually, about  40,000 individuals are affected by radiation damage to the salivary glands secondary to head and neck cancer radiation therapy. Salivary gland hypofunction significantly compromises the quality of life of those individuals through poor oral health and neglect and non-compliance of drug treatments that reduce salivary flow. Options for those who suffer from salivary hypofunction are limited and at best palliative. Therefore, studies by Drs. Huang and Yan using dental stem cells to regenerate functional salivary glands are at the scientific forefront of finding real solutions to millions affected by poor salivary function.
Download
 
01/24/2011 - Human dental pulp stem cells produce mineralized matrix in 2D and 3D cultures.

Eur J Histochem. 2010 Nov 10;54(4):e46.

Riccio M, Resca E, Maraldi T, Pisciotta A, Ferrari A, Bruzzesi G, De Pol A.

Dept. Anatomy and Histology, University of Modena and Reggio Emilia. massimo.riccio@unimore.it.

The aim of this study was to characterize the in vitro osteogenic differentiation of dental pulp stem cells (DPSCs) in 2D cultures and 3D biomaterials. DPSCs, separated from dental pulp by enzymatic digestion, and isolated by magnetic cell sorting were differentiated toward osteogenic lineage on 2D surface by using an osteogenic medium. During the differentiation process, DPSCs express specific bone proteins like Runx-2, Osx, OPN and OCN with a sequential expression, analogous to those occurring during osteoblast differentiation, and produce extracellular calcium deposits. In order to differentiate cells in a 3D space that mimes the physiological environment, DPSCs were cultured in two distinct bioscaffolds, MatrigelTM and Collagen sponge. With the addition of a third dimension, osteogenic differentiation and mineralized extracellular matrix production significantly improved. In particular, in MatrigelTM DPSCs differentiated with osteoblast/osteocyte characteristics and connected by gap junction, and therefore formed calcified nodules with a 3D intercellular network. Furthermore, DPSCs differentiated in collagen sponge actively secrete human type I collagen micro-fibrils and form calcified matrix containing trabecular-like structures. These neo-formed DPSCs-scaffold devices may be used in regenerative surgical applications in order to resolve pathologies and traumas characterized by critical size bone defects.

Download
 
01/24/2011 - Integration of neuronally predifferentiated human dental pulp stem cells into rat brain in vivo.

Neurochem Int. 2011 Jan 8.

Király M, Kádár K, Horváthy DB, Nardai P, Rácz GZ, Lacza Z, Varga G, Gerber G.

Department of Oral Biology, Semmelweis University, Nagyvarad ter 4, 1089 Budapest, Hungary.

Abstract

Pluripotency and their neural crest origin make dental pulp stem cells (DPSCs) an attractive donor source for neuronal cell replacement. Despite recent encouraging results in this field, little is known about the integration of transplanted DPSC derived neuronal pecursors into the central nervous system. To address this issue, NFneuronally predifferentiated DPSCs, labeled with a vital cell dye Vybrant DiD were introduced into postnatal rat brain. DPSCs were transplanted into the cerebrospinal fluid of 3-day-old male Wistar rats. Cortical lesion was induced by touching a cold (-60°C) metal stamp to the calvaria over the forelimb motor cortex. Four weeks later cell localization was detected by fluorescent microscopy and neuronal cell markers were studied by immunohistochemistry. To investigate electrophysiological properties of engrafted, fluorescently labeled DPSCs, 300µm-thick horizontal brain slices were prepared and the presence of voltage-dependent sodium and potassium channels were recorded by patch clamping. Predifferentiated donor DPSCs injected into the cerebrospinal fluid of newborn rats migrated as single cells into a variety of brain regions. Most of the cells were localized in the normal neural progenitor zones of the brain, the subventricular zone (SVZ), subgranular zone (SGZ) and subcallosal zone (SCZ). Immunohistochemical analysis revealed that transplanted DPSCs expressed the early neuronal marker N-tubulin, the neuronal specific intermediate filament protein NF-M, the postmitotic neuronal marker NeuN, and glial GFAP. Moreover, the cells displayed TTX sensitive voltage dependent (VD) sodium currents (I(Na)) and TEA sensitive delayed rectifier potassium currents (K(DR)). Four weeks after injury, fluorescently labeled cells were detected in the lesioned cortex. Neurospecific marker expression was increased in DPSCs found in the area of the cortical lesions compared to that in fluorescent cells of uninjured brain. TTX sensitive VD sodium currents and TEA sensitive K(DR) significantly increased in labeled cells of the cortically injured area. In conclusion, our data demonstrate that engrafted DPSC-derived cells integrate into the host brain and show neuronal properties not only by expressing neuron-specific markers but also by exhibiting voltage dependent sodium and potassium channels. This proof of concept study reveals that predifferentiated hDPSCs may serve as useful sources of neuro- and gliogenesis in vivo, especially when the brain is injured.

Download
 
01/24/2011 - Effect of platelet-rich plasma on dental stem cells derived from human impacted third molars.

Regen Med. 2011 Jan;6(1):67-79.

Lee UL, Jeon SH, Park JY, Choung PH.

Department of Oral & Maxillofacial Surgery, School of Dentistry, Seoul National University, Seoul, South Korea.

Abstract

AIM: Platelet-rich plasma (PRP) is fabricated from autologous blood and extensively used to promote soft and hard tissue healing. In the dental field, autologous PRP is widely used combined with dental implant installation and bone graft. This study will evaluate the biologic effect of PRP on the proliferation and the differentiation of human dental stem cells, and find the key cytokines inducing these effects to estimate the clinical feasibility of PRP for dental tissue engineering.

MATERIALS & METHODS: Venous blood was obtained from four individuals and each PRP was fabricated. The human dental stem cells were obtained from the periodontal ligament (PDL) and dental pulp of the surgically extracted human third molars and expanded in vitro. Immunocytochemical staining and flow cytometry with STRO-1 and CD146 confirmed existence of mesenchymal stem cells in the PDL and dental pulp. The effect of PRP on the proliferation of PDL stem cells (PDLSCs) and dental pulp stem cells (DPSCs) was assessed by colony-forming ability measurement, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and bromodeoxyuridine incorporation assay. Alkaline phosphatase activity and calcium deposit were measured to evaluate the mineralization effect of PRP PDLSCs and DPSCs. Alizarin red S staining was used to detect mineral nodules. Odontogenic and osteogenic gene expressions were evaluated in the PRP-treated PDLSCs and DPSCs by real-time quantitative PCR. A protein array was performed to detect the key cytokines that have an important role in the tissue regenerative effect of PRP.

RESULTS: Flow cytometry cell sorting showed that the cells from human PDL and dental pulp contained mesenchymal stem cell populations. Colony-forming ability and cellular proliferation of the dental stem cells were increased at 0.5 and 1% PRP concentration but decreased at 5% concentration. Long-term treatment with 1% PRP enhanced proliferation of the human dental stem cells PDLSCs and DPSCs by 120 h and showed the most significant enhancement at 96 h. PRP also promoted mineralization differentiation of the two kinds of dental stem cells as shown by measurement of alkaline phosphatase activity and calcium deposit under mineralization conditioned media. Increased formation of mineral nodules stained with alizarin red was observed in both PDLSCs and DPSCs after treatment with 1% PRP. Real-time quantitative PCR showed higher odontogenic and osteogenic gene expressions in PRP-treated PDLSCs and DPSCs. RANTES/CCL5 and ICAM-1 were the two key cytokines that were detected in human cytokine array with PRP.

CONCLUSION: The appropriate concentration of the PRP treatment enhanced proliferation and mineralization differentiation of human dental stem cells. RANTES/CCL5 and ICAM-1 might play an important role in PRP-induced tissue regeneration but further study is needed to investigate the whole mechanism.

Download
 
12/12/2010 - Researchers at Boston University use stem cells to repair teeth

Doctor George Huang discusses baby teeth and wisdom teeth as a potential source of stem cells that can be utilized in the treatment of disease and trauma.  

By Doctor Alan A. Winter, DDS

Boston University Professor Doctor George Huang, the Herber